DisclosurePeptide Association LLC is a for-profit company. We do not refer patients to providers or earn anything from treatment or product sales. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.

Receipts · last updated 2026-11-13

Who pays us.

Peptide Association LLC is a for-profit company. You should know who pays us before you take our word for anything.

Most organisations with “Association” in the name are trade bodies: they represent practitioners, and their members are the professionals. We are the other kind. Our members are the people using peptide therapy. Clinicians and pharmacies are partners who serve those members.

We are not an accrediting body, a licensing board, or a government-affiliated organisation. We do not refer patients to providers, and no provider pays us. What we can do is show you every way we are paid and let you weigh it.

Providers who pay us
none
Paid placement in results
none
Paid per patient
none
Rejection log
pending

01

Every way we earn

Neither line is paid per patient. You are entitled to hold us to that.

  1. 01

    Memberships

    Paid by members

    Members pay us directly for the full protocol library, webinar recordings and regulatory alerts. Member dues are paid by members, so they are the part of our revenue that answers only to members.

  2. 02

    Sponsorships

    Flat fee, not per patient

    Pharmacies, suppliers, labs and software vendors pay flat quarterly fees for named placements. Set in advance, never tied to the volume or value of any patient referral, and never able to buy clinical placement.

02

Does payment affect listing order?

No provider pays us. We do not refer patients to providers, and no one can pay for placement or listing order.

Providers who pay us: none · Paid placement in results: none.

03

Who we turned down

Providers and sponsors who wanted to pay us, and why we said no.

PendingThe rejection log is not yet published. We are confirming every entry before it goes live, rather than posting something we would have to correct.

04

What we have refused to sell

Promises are cheap. These are decisions that cost us revenue, and you can verify each one on the site.

  1. 01

    We removed the retatrutide purchase path

    Retatrutide is investigational, has no lawful US compounding pathway, and we were marketing access to it. We deleted the acquisition section and kept the published research. The page still gets traffic; it no longer converts.

  2. 02

    We took the Outcomes Registry offline

    It advertised the largest real-world peptide outcomes dataset in existence. The dataset did not exist yet, so the pages now return a 410 rather than collect sign-ups against a claim we could not support.

  3. 03

    We stopped calling ourselves an accrediting body

    We are not one. We removed the certification product, the credentialing language, and the verified-provider badge claims. We review licensure against the CMS registry; we do not license, credential, or accredit anyone.

  4. 04

    We removed our own countdown timers

    Manufactured scarcity on health decisions is manipulation. If a real limit exists, like one sponsor per category per quarter, we will tell you the actual number. If there is no limit, we will not invent one.

05

Holding us to it

If you find a claim on this network you think we cannot support, tell us and we will either source it or remove it. That is the same standard we applied to our own pages, and several of them did not survive it.

Read our editorial policy for how content is researched and reviewed, or contact us directly. Companies interested in flat-fee placements can read the terms on our sponsorship page.